Enhanced Inhibition of Syngeneic Murine Tumors by Combinatorial Therapy With Genetically Engineered HSV-1 Expressing CCL2 and IL-12

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700784
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search